pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Advicenne is a late-stage pharmaceutical company focusing on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases.
LOCATION
THERAPEUTIC AREAS
Kidney Disease
Neurological DIsorders
Rare Diseases
WEBSITE
https://www.advicenne.com/
CAREER WEBSITE
None
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Dec 13, 2022
Advicenne Obtains Orphan Drug Designation for ADV7103 in the United States for the Treatment of Distal Renal Tubular Acidosis (dRTA)
Nov 3, 2022
Advicenne Announces Its Upcoming Participation in Two of the Most Important International Investor Conferences
Oct 5, 2022
Advicenne Announces the Extension of the Intellectual Property of Its Drug Sibnayal
Sep 21, 2022
Advicenne Reports Its First Half Financial Results as of June 30, 2022
Sep 14, 2022
Advicenne Updates on Availability of Sibnayal to Patients and Caregivers in Great Britain
For More Press Releases